Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Ohio Recovery Housing (ORH) Repairs Fund Application Open for Eligible Applicants

Client Alert
April 14, 2023

The Ohio Recovery Housing (ORH) Repairs Fund Application is open for eligible organizations and/or operators of recovery housing facilities throughout the state of Ohio!

Funded by the Ohio Department of Mental Health and Addiction Services (OHMHAS) and the Ohio Department of Development (ODD), this opportunity is open for non-ORH certified recovery housing operators seeking to gain certification through ORH and help expand housing opportunities throughout the state of Ohio. Eligible applicants include operators:

  1. who meet the Ohio statutory definition of “Recovery Housing.” See R.C. §340.01(A)(3);
  2. are not currently certified by ORH; and
  3. are owned by the organization operating the recovery house or by the county ADM board.

Eligible applicants may apply for up to $10,000.00 per property (refunded by ORH subsequent to repairs), and funds must be used for physical improvements identified during the ORH certification and inspection processes. The application as well as other certification criteria can be found on the ORH website.

If you have any questions regarding your eligibility for this funding opportunity, or need any assistance in the ORH application and/or certification processes, please contact Monica Andress at (330) 253-9153 or mbandress@bmdllc.com.

Ohio Recovery Housing
Client Alert

Name, Image, and Likeness Agreements in Healthcare

November 14, 2025For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.Client Alert

Compounding GLP-1 Drugs - Recent Updates

November 13, 2025Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.Client Alert

Top Compliance Risks for Ohio Med-Spas in 2025

November 11, 2025The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.Client Alert

Pre and Postnuptial Agreements | Necessary, Maybe, What Happened to Forever?

November 7, 2025Both Florida and Ohio now allow clients to enter into a prenuptial or postnuptial agreement prior to marriage or after marriage (Ohio previously did not allow postnuptial agreements). Both documents have statutory guidelines that must be followed in terms of execution and financial disclosure.Client Alert

DHS Ends All Employment Authorization Auto-Extensions

October 29, 2025Effective October 30, 2025, DHS ends all automatic work authorization renewals. The 540-day extension applies only to renewals filed before this date, and there is no grace period for expired EADs filed on or after October 30. Employers must audit EADs, train staff, ensure I-9 compliance, and plan for work authorization gaps. Penalties for noncompliance can be severe.
Older posts